Zhejiang Hisun Pharmaceutical Co Ltd (600267) — Cash Flow Quality Index
Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a Cash Flow Quality Index of 2.71x as of September 2025. Operating cash flow of CN¥438.43 Million exceeds net income of CN¥161.86 Million, indicating high earnings quality where cash backs reported profits. Explore 600267 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Hisun Pharmaceutical Co Ltd Cash Flow Quality Index (1999–2025)
Historical Cash Flow Quality Index for Zhejiang Hisun Pharmaceutical Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Zhejiang Hisun Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Zhejiang Hisun Pharmaceutical Co Ltd (1999–2025)
Year-by-year earnings quality comparison for Zhejiang Hisun Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see market cap of Zhejiang Hisun Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.76x | CN¥2.03 Billion | CN¥540.71 Million | ▲ +5.1% |
| 2024 | 3.58x | CN¥2.11 Billion | CN¥591.31 Million | ▼ -14.9% |
| 2022 | 4.20x | CN¥2.07 Billion | CN¥491.42 Million | ▲ +23.6% |
| 2021 | 3.40x | CN¥1.74 Billion | CN¥510.63 Million | ▲ +54.7% |
| 2020 | 2.20x | CN¥1.59 Billion | CN¥723.17 Million | ▲ +1.7% |
| 2019 | 2.16x | CN¥698.39 Million | CN¥323.27 Million | ▼ -59.7% |
| 2017 | 5.36x | CN¥1.24 Billion | CN¥231.57 Million | ▼ -57.3% |
| 2016 | 12.54x | CN¥775.90 Million | CN¥61.85 Million | ▲ +115.2% |
| 2015 | 5.83x | CN¥736.17 Million | CN¥126.30 Million | ▲ +463.4% |
| 2014 | 1.03x | CN¥571.04 Million | CN¥551.97 Million | ▼ -0.4% |
| 2013 | 1.04x | CN¥527.25 Million | CN¥507.52 Million | ▼ -25.6% |
| 2012 | 1.40x | CN¥375.75 Million | CN¥269.05 Million | ▲ +37.0% |
| 2011 | 1.02x | CN¥525.31 Million | CN¥515.45 Million | ▼ -25.1% |
| 2010 | 1.36x | CN¥509.18 Million | CN¥374.35 Million | ▼ -19.8% |
| 2009 | 1.70x | CN¥472.85 Million | CN¥278.70 Million | ▲ +53.9% |
| 2008 | 1.10x | CN¥221.28 Million | CN¥200.69 Million | ▼ -64.0% |
| 2007 | 3.06x | CN¥437.72 Million | CN¥142.83 Million | ▲ +131.0% |
| 2006 | 1.33x | CN¥108.03 Million | CN¥81.43 Million | ▲ +38.7% |
| 2005 | 0.96x | CN¥113.53 Million | CN¥118.68 Million | ▼ -33.1% |
| 2004 | 1.43x | CN¥312.93 Million | CN¥218.79 Million | ▼ -13.7% |
| 2003 | 1.66x | CN¥288.45 Million | CN¥174.08 Million | ▼ -27.8% |
| 2002 | 2.30x | CN¥120.82 Million | CN¥52.63 Million | ▲ +63.0% |
| 2001 | 1.41x | CN¥69.14 Million | CN¥49.07 Million | ▲ +39.3% |
| 2000 | 1.01x | CN¥55.70 Million | CN¥55.09 Million | ▲ +55.3% |
| 1999 | 0.65x | CN¥32.64 Million | CN¥50.15 Million | — |